Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
NVIDIA
NVDA
Vale SA
VALE
KB Home
KBH
US Stock MarketDetailed Quotes
MRNA Moderna
- 32.990
- +1.070+3.35%
Close Feb 14 16:00 ET
- 32.900
- -0.090-0.27%
Post 19:59 ET
12.70BMarket Cap-3.55P/E (TTM)
33.910High29.250Low25.33MVolume30.530Open31.920Pre Close822.30MTurnover7.30%Turnover RatioLossP/E (Static)384.82MShares170.47052wk High1.16P/B11.45BFloat Cap29.25052wk Low--Dividend TTM347.11MShs Float497.490Historical High--Div YieldTTM14.60%Amplitude11.540Historical Low32.467Avg Price1Lot Size
About Moderna Company
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
Company Profile
SymbolMRNA
Company NameModerna
Listing DateDec 7, 2018
Issue Price23.00
Founded2010
CEOMr. Stephane Bancel
MarketNASDAQ
Employees5600
Fiscal Year Ends12-31
Address325 Binney Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-714-6500
Websitehttp://www.modernatx.com
Company Executives
- Name
- Position
- Salary
- Stephane Bancel
- Director and Chief Executive Officer
- 17.07M
- James M Mock
- Chief Financial Officer and Principal Accounting Officer
- 4.32M
- Shannon Thyme Klinger
- Chief Legal Officer and Corporate Secretary
- 4.31M
- Brad Miller
- Chief Information Officer
- --
- Tracey Franklin
- Chief Human Resources Officer
- --
- Kate Cronin
- Chief Brand Officer
- --
- Jerh Collins
- Chief Technical Operations and Quality Officer
- --
- Dr. Noubar B. Afeyan, PhD
- Chairman of the Board
- 663.52K
- Dr. Stephen Hoge, M.D.
- President
- 7.34M
- Abbas Hussain
- Director
- --
- David M. Rubenstein
- Director
- --
- Dr. Sandra J. Horning, M.D.
- Independent Director
- 481.27K
- Dr. Elizabeth G. Nabel, M.D.
- Independent Director
- 476.25K
- Elizabeth E. Tallett
- Independent Director
- 481.27K
- Paul Sagan
- Independent Director
- 461.27K
- Dr. Francois Nader, M.D.
- Independent Director
- 481.27K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
